The present invention is related to heterocycles represented by a compound of Formula I that are novel allosteric modulators of α7 nAChRs and/or GABAA receptors. The invention also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on α7 nAChRs and negative allosteric modulation of GABAA receptors in a mammal by administering an effective amount of a compound of Formula I.
本发明涉及由式I化合物表示的杂环,它们是α7 nAChR和/或
GABAA受体的新型异构调节剂。本发明还揭示了通过给哺乳动物施用式I化合物的有效量来治疗对
乙酰胆碱作用于α7 nAChR的增强和
GABAA受体的负异构调节有反应的障碍。